Concord Biotech Limited
2,942words
0turns
0analyst exchanges
0executives
Key numbers — 40 extracted
rs,
ol: CONCORDBIO To General Manager, Lis(cid:415)ng Department BSE Limited Phiroze Jeejabhoy Towers, Dalal Street, Mumbai – 400 001 Scrip Code: 543960 Dear Sir/Ma’am, Sub.: Investor’s Presenta(ci
35%
4 Consolidated Financial Highlights Revenue (Rs. in Crs) EBIDTA* (Rs. in Crs) PAT (Rs. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2
65%
d Financial Highlights Revenue (Rs. in Crs) EBIDTA* (Rs. in Crs) PAT (Rs. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2 37.4 22.0
79%
enue (Rs. in Crs) EBIDTA* (Rs. in Crs) PAT (Rs. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2 37.4 22.0 Q2FY23 Q2FY24 H1FY23 H1
209%
Crs) EBIDTA* (Rs. in Crs) PAT (Rs. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2 37.4 22.0 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23
90%
Crs) PAT (Rs. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2 37.4 22.0 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY
269%
s. in Crs) +35% 457.2 +65% 339.9 262.4 158.9 +79% 193.9 +209% 115.7 108.2 +90% 135.5 +269% 81.0 71.2 37.4 22.0 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 Q2FY23 Q2
180 bps
FY24 Q2FY23 Q2FY24 H1FY23 H1FY24 Gross Profit Margin (%) EBIDTA Margin* (%) PAT Margin (%) +180 bps +140 bps +2050 bps +1060 bps +1710 bps +860 bps 78.0% 79.8% 78.2% 79.6% 44.1% 42.4% 30.
140 bps
23 Q2FY24 H1FY23 H1FY24 Gross Profit Margin (%) EBIDTA Margin* (%) PAT Margin (%) +180 bps +140 bps +2050 bps +1060 bps +1710 bps +860 bps 78.0% 79.8% 78.2% 79.6% 44.1% 42.4% 30.9% 29.6%
2050 bps
H1FY23 H1FY24 Gross Profit Margin (%) EBIDTA Margin* (%) PAT Margin (%) +180 bps +140 bps +2050 bps +1060 bps +1710 bps +860 bps 78.0% 79.8% 78.2% 79.6% 44.1% 42.4% 30.9% 29.6% 23.6% 31.
1060 bps
1FY24 Gross Profit Margin (%) EBIDTA Margin* (%) PAT Margin (%) +180 bps +140 bps +2050 bps +1060 bps +1710 bps +860 bps 78.0% 79.8% 78.2% 79.6% 44.1% 42.4% 30.9% 29.6% 23.6% 31.8% 13.8%
1710 bps
s Profit Margin (%) EBIDTA Margin* (%) PAT Margin (%) +180 bps +140 bps +2050 bps +1060 bps +1710 bps +860 bps 78.0% 79.8% 78.2% 79.6% 44.1% 42.4% 30.9% 29.6% 23.6% 31.8% 13.8% 21.0% Q2FY
Advertisement